Skip to main content

CITADEL ADVISORS LLC

Position in PRME — Prime Medicine, Inc.

CIK 1423053 MIAMI, FL

Position in PRME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,581,263
+$6,410,738 QoQ
Shares Held
2,054,543
+510.8% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 186 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRME Over Time

Shares Held

Position Value (USD)

Derivatives in PRME

reported options exposure · as of Jun 30, 2026
CallValue
$591,138
CallShares
160,200
PutValue
$511,803
PutShares
138,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. PRME ranks #115 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PRME

Export CSV
33 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,581,263 2,054,543
2026-06-30 $511,803 138,700
2026-06-30 $591,138 160,200
2026-03-31 $561,324 161,300
2026-03-31 $1,170,525 336,358
2026-03-31 $349,392 100,400
2025-12-31 $656,177 189,100
2025-12-31 $391,658 112,870
2025-12-31 $709,268 204,400
2025-09-30 $4,986,786 900,142
2025-09-30 $724,632 130,800
2025-09-30 $1,080,854 195,100
2025-06-30 $186,732 75,600
2025-06-30 $1,288,124 521,508
2025-06-30 $417,924 169,200
2025-03-31 $170,941 85,900
2025-03-31 $4,776 2,400
2024-12-31 $124,392 42,600
2024-12-31 $279,736 95,800
2024-09-30 $193,887 50,100
2024-09-30 $197,350 50,995
2024-09-30 $17,415 4,500
2024-06-30 $380,360 74,000
2024-06-30 $65,411 12,726
2024-06-30 $22,102 4,300
2024-03-31 $403,900 57,700
2024-03-31 $41,300 5,900
2024-03-31 $757,386 108,198
2023-12-31 $7,974 900
2023-12-31 $372,120 42,000
2023-09-30 $97,308 10,200
2023-09-30 $9,540 1,000
2023-09-30 $62,238 6,524